196 related articles for article (PubMed ID: 30426109)
1. A Novel CLCN5 Mutation Associated With Focal Segmental Glomerulosclerosis and Podocyte Injury.
Solanki AK; Arif E; Morinelli T; Wilson RC; Hardiman G; Deng P; Arthur JM; Velez JC; Nihalani D; Janech MG; Budisavljevic MN
Kidney Int Rep; 2018 Nov; 3(6):1443-1453. PubMed ID: 30426109
[TBL] [Abstract][Full Text] [Related]
2. Dent's disease: Identification of seven new pathogenic mutations in the CLCN5 gene.
Ramos-Trujillo E; Claverie-Martin F; Garcia-Nieto V; Ariceta G; Vara J; Gonzalez-Acosta H; Garcia-Ramirez M; Fons J; Cordoba-Lanus E; Gonzalez-Paredes J; Valenciano B; Ramos L; Muley R; Caggiani M; Alvarez-Estrada P; Madrid A;
J Pediatr Genet; 2013 Sep; 2(3):133-40. PubMed ID: 27625851
[TBL] [Abstract][Full Text] [Related]
3. Clinical and genetic studies of CLCN5 mutations in Japanese families with Dent's disease.
Igarashi T; Inatomi J; Ohara T; Kuwahara T; Shimadzu M; Thakker RV
Kidney Int; 2000 Aug; 58(2):520-7. PubMed ID: 10916075
[TBL] [Abstract][Full Text] [Related]
4. [A rare tubulopathy: Dent's disease in the background of focal segmental glomerular sclerosis].
Jakab D; Maróti Z; Iványi B; Bereczki C; Kalmár T
Orv Hetil; 2023 May; 164(20):788-791. PubMed ID: 37210717
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of a novel missense CLCN5 mutation causing alterations in proximal tubular endocytic machinery in Dent's disease.
Tanuma A; Sato H; Takeda T; Hosojima M; Obayashi H; Hama H; Iino N; Hosaka K; Kaseda R; Imai N; Ueno M; Yamazaki M; Sakimura K; Gejyo F; Saito A
Nephron Physiol; 2007; 107(4):p87-97. PubMed ID: 18025833
[TBL] [Abstract][Full Text] [Related]
6. New Mutation of Coenzyme Q
Song CC; Hong Q; Geng XD; Wang X; Wang SQ; Cui SY; Guo MD; Li O; Cai GY; Chen XM; Wu D
Chin Med J (Engl); 2018 Nov; 131(22):2666-2675. PubMed ID: 30425193
[TBL] [Abstract][Full Text] [Related]
7. Evidence for genetic heterogeneity in Dent's disease.
Hoopes RR; Raja KM; Koich A; Hueber P; Reid R; Knohl SJ; Scheinman SJ
Kidney Int; 2004 May; 65(5):1615-20. PubMed ID: 15086899
[TBL] [Abstract][Full Text] [Related]
8. Rho-GTPase Activating Protein myosin MYO9A identified as a novel candidate gene for monogenic focal segmental glomerulosclerosis.
Li Q; Gulati A; Lemaire M; Nottoli T; Bale A; Tufro A
Kidney Int; 2021 May; 99(5):1102-1117. PubMed ID: 33412162
[TBL] [Abstract][Full Text] [Related]
9. Four additional CLCN5 exons encode a widely expressed novel long CLC-5 isoform but fail to explain Dent's phenotype in patients without mutations in the short variant.
Ludwig M; Waldegger S; Nuutinen M; Bökenkamp A; Reissinger A; Steckelbroeck S; Utsch B
Kidney Blood Press Res; 2003; 26(3):176-84. PubMed ID: 12886045
[TBL] [Abstract][Full Text] [Related]
10. Phenotype and genotype of Dent's disease in three Chinese boys.
Li P; Huang JP
Nephrology (Carlton); 2009 Apr; 14(2):139-42. PubMed ID: 19076289
[TBL] [Abstract][Full Text] [Related]
11. A Study on the CLCN5 Gene in Iranian Patients: A Report of Novel and Recurrent Mutations.
Mollataheri A; Mojbafan M; Hosseini R; Houman N; Mousavi M; Otoukesh H
Nephron; 2023; 147(8):470-477. PubMed ID: 36646056
[TBL] [Abstract][Full Text] [Related]
12. Protecting Podocytes: A Key Target for Therapy of Focal Segmental Glomerulosclerosis.
Campbell KN; Tumlin JA
Am J Nephrol; 2018; 47 Suppl 1(Suppl 1):14-29. PubMed ID: 29852493
[TBL] [Abstract][Full Text] [Related]
13. Renal chloride channel, CLCN5, mutations in Dent's disease.
Cox JP; Yamamoto K; Christie PT; Wooding C; Feest T; Flinter FA; Goodyer PR; Leumann E; Neuhaus T; Reid C; Williams PF; Wrong O; Thakker RV
J Bone Miner Res; 1999 Sep; 14(9):1536-42. PubMed ID: 10469281
[TBL] [Abstract][Full Text] [Related]
14. Characterization of renal chloride channel (CLCN5) mutations in Dent's disease.
Yamamoto K; Cox JPDT; Friedrich T; Christie PT; Bald M; Houtman PN; Lapsley MJ; Patzer L; Tsimaratos M; Van't Hoff WG; Yamaoka K; Jentsch TJ; Thakker RV
J Am Soc Nephrol; 2000 Aug; 11(8):1460-1468. PubMed ID: 10906159
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of the CLCN5 gene in Dent's disease: first mutation identified in a patient from South America.
Ramos-Trujillo E; Garcia-Nieto V; Gonzalez-Acosta H; Vara J; Pérez-Diaz V; Nadal I; Oliveros R; Claverie-Martin F
Clin Nephrol; 2007 Dec; 68(6):367-72. PubMed ID: 18184518
[TBL] [Abstract][Full Text] [Related]
16. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
[TBL] [Abstract][Full Text] [Related]
17. The role of podocyte injury in the pathogenesis of focal segmental glomerulosclerosis.
Schwartz MM
Ren Fail; 2000 Nov; 22(6):663-84. PubMed ID: 11104157
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the gene that encodes the F-actin binding protein anillin cause FSGS.
Gbadegesin RA; Hall G; Adeyemo A; Hanke N; Tossidou I; Burchette J; Wu G; Homstad A; Sparks MA; Gomez J; Jiang R; Alonso A; Lavin P; Conlon P; Korstanje R; Stander MC; Shamsan G; Barua M; Spurney R; Singhal PC; Kopp JB; Haller H; Howell D; Pollak MR; Shaw AS; Schiffer M; Winn MP
J Am Soc Nephrol; 2014 Sep; 25(9):1991-2002. PubMed ID: 24676636
[TBL] [Abstract][Full Text] [Related]
19. Secondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to Glomerulosclerosis.
Kim JS; Han BG; Choi SO; Cha SK
Biomed Res Int; 2016; 2016():1630365. PubMed ID: 27088082
[TBL] [Abstract][Full Text] [Related]
20. Podocyte-Specific Sialylation-Deficient Mice Serve as a Model for Human FSGS.
Niculovic KM; Blume L; Wedekind H; Kats E; Albers I; Groos S; Abeln M; Schmitz J; Beuke E; Bräsen JH; Melk A; Schiffer M; Weinhold B; Münster-Kühnel AK
J Am Soc Nephrol; 2019 Jun; 30(6):1021-1035. PubMed ID: 31040189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
